• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Future4Care Launches in Paris, Imperial College Healthcare NHST Trust and Luscii Partner

Share:

June 21, 2021

EUROPEAN HEALTHCARE STARTUP ACCELERATOR LAUNCHES IN PARIS

Sanofi, Capgemini, Generali, and Orange have announced the creation of a joint venture called “Future4care”, a European health-focused startup accelerator program.

The initiative aims to stimulate the development of eHealth solutions and their go-to-market, for the benefit of both patients and health professionals.

The startup selection process is based on two routes: either applications in response to a specific call for projects or a spontaneous application. The first call for projects will be launched in September 2021 around two themes: virtual care using digital tools and personalized care.

Startups choosing to join Future4care benefit from personalized support through a series of thematic labs including creative lab; medical/regulatory lab; business and ethics lab; data & AI lab; and living lab.

CQC RATES LIVI OUTSTANDING

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

UK-based medical app Livi has announced that it has become the first digital healthcare provider in England to be rated Outstanding by the Care Quality Commission (CQC), the independent regulator of health and social care services.

The CQC report was based on an inspection that took place on 5 May 2021, with Livi awarded an Outstanding rating in two out of five categories and a good rating in the other three, leading to an overall Outstanding rating. Just 5% of GP practices were rated Outstanding by the CQC in 2020. This is the first time Livi has been inspected by the regulator.

Inspectors highlighted Livi’s work throughout the COVID-19 pandemic when the company was asked by NHS England to run the COVID Home Monitoring Service (CHMS). The CHMS allowed patients 24-hour access to care, seven days a week, without the risk of exposing others to COVID-19.

SALFORD LAUNCHES HEART FAILURE PATIENT PROJECT

Healthcare teams at Salford Care Organisation, part of the Northern Care Alliance Group, are piloting the use of a remote monitoring system that uses a smartphone app and easy-to-use connected Bluetooth devices.

The device encourages patients to self-manage and records their weight and blood pressure between appointments. The new system developed by Norwegian medical tech firm Dignio automatically sends patients’ readings direct to clinicians at Salford Royal via a special data platform.

Through the pilot, users will have access to the Dignio App to record their measurements manually and a set of digital scales and blood pressure monitors.

The platform flags up any signs which indicate their condition is deteriorating between visits and clinicians are alerted when something falls outside the acceptable range.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Best Buy Health Launches Phone for Seniors w/ Amazon Alexa Voice ServicesBest Buy Health Launches Phone for Seniors w/ Amazon Alexa Voice Services
  • Aveanna Healthcare to Acquire Maxim Healthcare Services’ Home Healthcare DivisionAveanna Healthcare to Acquire Maxim Healthcare Services’ Home Healthcare Division
  • Samsung Researchers Develop Stretchable Heart Rate Monitoring Skin PatchSamsung Researchers Develop Stretchable Heart Rate Monitoring Skin Patch
  • New Indication for Consumer Congestion Relief DeviceNew Indication for Consumer Congestion Relief Device
  • Thermo Fisher Scientific to Acquire the Binding Site GroupThermo Fisher Scientific to Acquire the Binding Site Group
  • Neupath Announces Clinic AcquisitionNeupath Announces Clinic Acquisition
  • India’s Bioeconomy Surge Towards $300 BillionIndia’s Bioeconomy Surge Towards $300 Billion
  • Repligen Announces Agreement to Acquire Avitide Inc.Repligen Announces Agreement to Acquire Avitide Inc.

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications